Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Ono Pharmaceutical Co. (OPHLF) had Normalized Pre-Tax Income of $196.88M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$731.81M |
|
$152.15M |
|
$180.67M |
|
$551.14M |
|
$538.69M |
|
$193.12M |
|
$3.77M |
|
$196.88M |
|
|
Normalized Pre-Tax Income |
$196.88M |
$152.23M |
|
$152.23M |
|
$152.23M |
|
$152.23M |
|
$193.12M |
|
$249.69M |
|
469.90M |
|
469.90M |
|
$0.32 |
|
$0.32 |
|
| Balance Sheet Financials | |
$2.75B |
|
$635.66M |
|
$4.08B |
|
$6.83B |
|
$837.65M |
|
$425.25M |
|
$495.89M |
|
$1.33B |
|
$5.50B |
|
$3.12B |
|
$5.50B |
|
469.91M |
|
| Cash Flow Statement Financials | |
$6.63M |
|
$21.56M |
|
$-137.66M |
|
$1.49B |
|
$1.38B |
|
$-110.28M |
|
-- |
|
$-110.07M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.28 |
|
-- |
|
-- |
|
0.07 |
|
0.12 |
|
75.31% |
|
26.39% |
|
26.39% |
|
-- |
|
26.90% |
|
20.79% |
|
$-5.85M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.51 |
|
0.89 |
|
101.49 |
|
2.77% |
|
4.88% |
|
2.23% |
|
2.57% |
|
$11.70 |
|
$-0.01 |
|
$0.01 |
|